You are here

Epizyme

Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million Upfront and $280 Million in Biobucks

BioSpace

Thu, 11/15/18 - 10:46 am

drug development

Boehringer Ingelheim

FDA gives Epizyme a green light on trial recruitment, but tazemetostat isn’t completely out of the woods yet

Endpoints

Mon, 09/24/18 - 09:45 am

clinical trials

Despite FDA hold, Epizyme’s tazemetostat posts positive interim data

Fierce Biotech

Fri, 06/15/18 - 09:53 pm

follicular lymphoma

FDA Pumps the Brakes on Epizyme’s Top Cancer Drug Tazemetostat

Xconomy

Mon, 04/23/18 - 10:44 pm

clinical trials

Why Epizyme Inc.'s Shares Skyrocketed Thursday

Motley Fool

Fri, 06/16/17 - 09:56 am

follicular lymphoma

Top Presentations to Look for at ASCO

Yahoo/24-7 Wall St

Tue, 05/30/17 - 11:35 am

Juno Therapeutics

Epizyme: Why Is Big Pharma Interested In This Small Biotech?

Seeking Alpha

Thu, 05/4/17 - 07:40 pm

Epizyme Earns $6 Million Milestone Payment from GlaxoSmithKline for Initiation of Clinical Development with First-in-Class PRMT5 Inhibitor

Yahoo

Thu, 09/15/16 - 09:26 am

PRMT5 inhibitors

Epizyme reports 2Q loss

Yahoo/AP

Mon, 08/8/16 - 09:57 am

Epizyme partners with Roche to test cancer drug combo

BioPharma Dive

Thu, 06/23/16 - 08:22 pm

PDL-1 inhibitors

diffuse large B-cell lymphoma

Epizyme’s Cancer Drug Studies to Continue; Some Tumors Wiped Out

Bloomberg

Mon, 06/20/16 - 09:53 am

non-Hodgkin's lymphoma

Epizyme lays out plans to have its cancer drug approved as soon as 2018

Bizjournals.com

Thu, 03/10/16 - 10:51 am

non-Hodgkin's lymphoma

10 Biotechs Short Sellers Are Betting Against

Yahoo/Benzinga

Wed, 12/30/15 - 10:40 am

Global Blood Therapeutics

Clovis Oncology

Puma Biotechnology

Myriad Genetics

For Epizyme chief executive, the work is personal

Boston Globe, MA

Sun, 12/6/15 - 10:18 am

non-Hodgkin’s lymphoma

Robert Bazemore

Epizyme Beats Out the Market With FDA Approval

Yahoo/24-7 Wall St

Mon, 08/24/15 - 05:00 pm

INI1-negative tumors

synovial sarcoma

Epizyme parts ways with its CEO ahead of big Phase II cancer bet

Fierce Biotech

Fri, 08/7/15 - 10:41 am

Epizyme reports 2Q loss

Yahoo/AP

Thu, 08/6/15 - 10:39 am

Celgene recommits to Epizyme, adding $620M in cancer drug bonuses

Fierce Biotech

Thu, 07/9/15 - 09:56 pm

Glimpse of promising lymphoma responses spurs a sharp spike in Epizyme shares

Fierce Biotech

Tue, 06/23/15 - 10:23 am

Epizyme reports 1Q loss

Yahoo/AP

Wed, 04/29/15 - 09:22 am

Pages